Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Seres Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- −3 vs. Q2 2022
- Shares held
- 104.7M
- +13.8M (+15.2%) vs. Q2 2022
- Total value
- $671.6M
- +$359.0M (+114.8%) vs. Q2 2022
- New holders
- 21
- 51 more added
- Sold out
- 24
- 29 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $17.9M |
| Q1 2026 | 33 | $20.5M |
| Q4 2025 | 36 | $36.4M |
| Q3 2025 | 32 | $40.9M |
| Q2 2025 | 33 | $25.4M |
| Q1 2025 | 63 | $43.1M |
| Q4 2024 | 69 | $52.5M |
| Q3 2024 | 77 | $60.1M |
| Q2 2024 | 93 | $50.0M |
| Q1 2024 | 99 | $66.3M |
| Q4 2023 | 103 | $125.4M |
| Q3 2023 | 134 | $255.6M |
| Q2 2023 | 138 | $538.1M |
| Q1 2023 | 123 | $593.9M |
| Q4 2022 | 124 | $588.2M |
| Q3 2022 | 120 | $671.6M |
| Q2 2022 | 123 | $312.7M |
| Q1 2022 | 131 | $537.2M |
| Q4 2021 | 148 | $642.8M |
| Q3 2021 | 133 | $555.1M |
| Q2 2021 | 147 | $1.93B |
| Q1 2021 | 154 | $1.85B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Silverarc Capital Management, LLC | 366,493 | $2.35M | 1.00% | +18,732+5.4% | Added |
| Nuveen Asset Management, LLC | 464,711 | $2.98M | 0.00% | +259,849+126.8% | Added |
| Lion Point Capital, LP | 626,803 | $3.23M | 1.31% | +145,000+30.1% | Added |
| Renaissance Technologies LLC | 538,900 | $3.46M | 0.00% | −337,507−38.5% | Reduced |
| Invesco Ltd. | 569,597 | $3.66M | 0.00% | +538,849+1,752.5% | Added |
| Price T Rowe Associates Inc | 572,991 | $3.68M | 0.00% | +4,282+0.8% | Added |
| Charles Schwab Investment Management Inc | 623,060 | $4.00M | 0.00% | +151,672+32.2% | Added |
| JPMorgan Chase & Co | 710,373 | $4.56M | 0.00% | −70,471−9.0% | Reduced |
| Northern Trust Corp | 734,481 | $4.71M | 0.00% | +57,673+8.5% | Added |
| Kynam Capital Management, LP | 772,820 | $4.96M | 1.05% | +514,173+198.8% | Added |
| Point72 Asset Management, L.P. | 939,429 | $6.03M | 0.03% | +604,429+180.4% | Added |
| Geode Capital Management, LLC | 1,506,494 | $9.67M | 0.00% | +287,746+23.6% | Added |
| Eversept Partners, LP | 1,935,825 | $12.4M | 1.47% | +1,935,825 | New |
| State Street Corp | 3,731,521 | $24.0M | 0.00% | +2,267,176+154.8% | Added |
| BlackRock Inc. | 6,300,350 | $40.5M | 0.00% | +539,617+9.4% | Added |
| Vanguard Group Inc | 6,610,856 | $42.4M | 0.00% | +1,280,039+24.0% | Added |
| Janus Henderson Group PLC | 11,163,248 | $71.7M | 0.05% | +5,792,839+107.9% | Added |
| Federated Hermes, Inc. | 18,499,136 | $118.8M | 0.35% | +516,880+2.9% | Added |
| FMR LLC | 18,610,733 | $119.5M | 0.01% | +9,521+0.1% | Added |
| Flagship Pioneering Inc. | 23,117,045 | $148.4M | 6.25% | +8,738,243+60.8% | Added |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −2,722,826−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −1,154,507−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,093,910−100.0% | Sold out |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −696,785−100.0% | Sold out |
| Nikko Asset Management Americas, Inc. | 0 | $0 | 0.00% | −696,785−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −475,121−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −340,890−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −336,056−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −217,674−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −213,156−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −179,003−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −131,774−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −99,950−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −72,542−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −43,148−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −37,897−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −32,468−100.0% | Sold out |
| Rothschild Investment Corp | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −16,598−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −14,643−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −14,326−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −7,135−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −287−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −36−100.0% | Sold out |